Therefore, HLA-class-II-negative (16/25) and selected constitutively HLA-class-II-expressing (9/22) melanoma cell lines were treated with IFN-γ for 24 and 48 h prior to the analyses of HLA class II surface expression, using flow cytometry. Here, IFNG is linked to melanoma.